Abstract
The article is devoted to the problems of using metabolic drugs that affect intracellular energy exchange processes. These drugs, which are proposed to be called energotropic, are becoming increasingly popular in modern medicine. The more urgent the task of determining the area of pathogenetic justification for their purpose becomes. The authors propose for discussion a range of indications for energotropic therapy. Various examples of the successful use of energotropic drugs in pediatrics are discussed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
